203 related articles for article (PubMed ID: 34691056)
1. Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief.
Andersen TK; Bodin J; Oftung F; Bogen B; Mjaaland S; Grødeland G
Front Immunol; 2021; 12():747032. PubMed ID: 34691056
[TBL] [Abstract][Full Text] [Related]
2. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
[TBL] [Abstract][Full Text] [Related]
3. Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza.
Tjärnhage E; Brown D; Bogen B; Andersen TK; Grødeland G
J Virol; 2023 Feb; 97(2):e0169422. PubMed ID: 36719241
[TBL] [Abstract][Full Text] [Related]
4. Broadly Protective CD8
Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
J Virol; 2021 May; 95(12):. PubMed ID: 33827939
[TBL] [Abstract][Full Text] [Related]
5. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
6. Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.
Grødeland G; Bogen B
Expert Rev Vaccines; 2015 Jun; 14(6):805-14. PubMed ID: 25818107
[TBL] [Abstract][Full Text] [Related]
7. Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin.
Grødeland G; Baranowska-Hustad M; Abadejos J; Blane TR; Teijaro J; Nemazee D; Bogen B
Front Immunol; 2020; 11():431. PubMed ID: 32269566
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.
Wang B; Yu H; Yang FR; Huang M; Ma JH; Tong GZ
Virol J; 2012 Jun; 9():127. PubMed ID: 22738661
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice.
Tan L; Lu H; Zhang D; Wang K; Tian M; Liu C; Liu Y; Hu B; Jin N
Sci China Life Sci; 2011 Apr; 54(4):293-9. PubMed ID: 21416231
[TBL] [Abstract][Full Text] [Related]
10. Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes.
Tan L; Lu H; Zhang D; Tian M; Hu B; Wang Z; Jin N
Virol J; 2010 Dec; 7():363. PubMed ID: 21134292
[TBL] [Abstract][Full Text] [Related]
11. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
Mooney AJ; Li Z; Gabbard JD; He B; Tompkins SM
J Virol; 2013 Jan; 87(1):363-71. PubMed ID: 23077318
[TBL] [Abstract][Full Text] [Related]
12. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
Kim YC; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2013 Dec; 172(2):579-88. PubMed ID: 23643528
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.
Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z
Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.
Grodeland G; Mjaaland S; Roux KH; Fredriksen AB; Bogen B
J Immunol; 2013 Sep; 191(6):3221-31. PubMed ID: 23956431
[TBL] [Abstract][Full Text] [Related]
15. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.
Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z
J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
Even-Or O; Samira S; Rochlin E; Balasingam S; Mann AJ; Lambkin-Williams R; Spira J; Goldwaser I; Ellis R; Barenholz Y
Vaccine; 2010 Sep; 28(39):6527-41. PubMed ID: 20412874
[TBL] [Abstract][Full Text] [Related]
18. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
19. A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.
Zheng L; Wang F; Yang Z; Chen J; Chang H; Chen Z
BMC Infect Dis; 2009 Feb; 9():17. PubMed ID: 19216752
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009.
Choi JY; Gwon YD; Kim JK; Cho YD; Heo YK; Cho HS; Choi TJ; Poo HR; Oh YK; Kim YB
PLoS One; 2013; 8(11):e80762. PubMed ID: 24260476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]